Sun Pharmaceutical Industries has shown resilience during market volatility, attracting investors seeking stability. Pharmaceutical companies generally perform well during uncertain economic conditions.
The company’s strong product pipeline and global presence support its growth outlook. Continued focus on specialty drugs is expected to improve profitability.
Sun Pharma remains a preferred choice for investors looking for defensive exposure in volatile markets.
